Medical aspects of pelvic inflammatory diseases

Abstract

Inflammatory pelvic diseases (IPD) are associated with increased incidence of sexually transmitted infections. The modern features of the PID course raise the question of including drugs improving therapy outcomes in the combination PID therapy. The development of chronic inflammatory processes is accompanied by changes in the body’s immune system, which serves as a basis for developing and finding new therapeutic agents and methods that have an effective therapeutic effect aimed at restoring the function of the impaired human immune status as a whole. The synthetic low molecular weight immunomodulating drug with anti-inflammatory activity aminodihydrophthalazinedione sodium possesses the above described therapeutic potential.

Keywords

• inflammatory pelvic diseases
• ipd
• endometritis
• sti